The role of memory in non-genetic inheritance and its impact on cancer treatment resistance.

Intra-tumour heterogeneity is a leading cause of treatment failure and disease progression in cancer. While genetic mutations have long been accepted as a primary mechanism of generating this heterogeneity, the role of phenotypic plasticity is becoming increasingly apparent as a driver of intra-tumo...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tyler Cassidy, Daniel Nichol, Mark Robertson-Tessi, Morgan Craig, Alexander R A Anderson
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2021
Materias:
Acceso en línea:https://doaj.org/article/d6c120fed11b4ebeb8bb0479a0ce7d3f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d6c120fed11b4ebeb8bb0479a0ce7d3f
record_format dspace
spelling oai:doaj.org-article:d6c120fed11b4ebeb8bb0479a0ce7d3f2021-12-02T19:58:00ZThe role of memory in non-genetic inheritance and its impact on cancer treatment resistance.1553-734X1553-735810.1371/journal.pcbi.1009348https://doaj.org/article/d6c120fed11b4ebeb8bb0479a0ce7d3f2021-08-01T00:00:00Zhttps://doi.org/10.1371/journal.pcbi.1009348https://doaj.org/toc/1553-734Xhttps://doaj.org/toc/1553-7358Intra-tumour heterogeneity is a leading cause of treatment failure and disease progression in cancer. While genetic mutations have long been accepted as a primary mechanism of generating this heterogeneity, the role of phenotypic plasticity is becoming increasingly apparent as a driver of intra-tumour heterogeneity. Consequently, understanding the role of this plasticity in treatment resistance and failure is a key component of improving cancer therapy. We develop a mathematical model of stochastic phenotype switching that tracks the evolution of drug-sensitive and drug-tolerant subpopulations to clarify the role of phenotype switching on population growth rates and tumour persistence. By including cytotoxic therapy in the model, we show that, depending on the strategy of the drug-tolerant subpopulation, stochastic phenotype switching can lead to either transient or permanent drug resistance. We study the role of phenotypic heterogeneity in a drug-resistant, genetically homogeneous population of non-small cell lung cancer cells to derive a rational treatment schedule that drives population extinction and avoids competitive release of the drug-tolerant sub-population. This model-informed therapeutic schedule results in increased treatment efficacy when compared against periodic therapy, and, most importantly, sustained tumour decay without the development of resistance.Tyler CassidyDaniel NicholMark Robertson-TessiMorgan CraigAlexander R A AndersonPublic Library of Science (PLoS)articleBiology (General)QH301-705.5ENPLoS Computational Biology, Vol 17, Iss 8, p e1009348 (2021)
institution DOAJ
collection DOAJ
language EN
topic Biology (General)
QH301-705.5
spellingShingle Biology (General)
QH301-705.5
Tyler Cassidy
Daniel Nichol
Mark Robertson-Tessi
Morgan Craig
Alexander R A Anderson
The role of memory in non-genetic inheritance and its impact on cancer treatment resistance.
description Intra-tumour heterogeneity is a leading cause of treatment failure and disease progression in cancer. While genetic mutations have long been accepted as a primary mechanism of generating this heterogeneity, the role of phenotypic plasticity is becoming increasingly apparent as a driver of intra-tumour heterogeneity. Consequently, understanding the role of this plasticity in treatment resistance and failure is a key component of improving cancer therapy. We develop a mathematical model of stochastic phenotype switching that tracks the evolution of drug-sensitive and drug-tolerant subpopulations to clarify the role of phenotype switching on population growth rates and tumour persistence. By including cytotoxic therapy in the model, we show that, depending on the strategy of the drug-tolerant subpopulation, stochastic phenotype switching can lead to either transient or permanent drug resistance. We study the role of phenotypic heterogeneity in a drug-resistant, genetically homogeneous population of non-small cell lung cancer cells to derive a rational treatment schedule that drives population extinction and avoids competitive release of the drug-tolerant sub-population. This model-informed therapeutic schedule results in increased treatment efficacy when compared against periodic therapy, and, most importantly, sustained tumour decay without the development of resistance.
format article
author Tyler Cassidy
Daniel Nichol
Mark Robertson-Tessi
Morgan Craig
Alexander R A Anderson
author_facet Tyler Cassidy
Daniel Nichol
Mark Robertson-Tessi
Morgan Craig
Alexander R A Anderson
author_sort Tyler Cassidy
title The role of memory in non-genetic inheritance and its impact on cancer treatment resistance.
title_short The role of memory in non-genetic inheritance and its impact on cancer treatment resistance.
title_full The role of memory in non-genetic inheritance and its impact on cancer treatment resistance.
title_fullStr The role of memory in non-genetic inheritance and its impact on cancer treatment resistance.
title_full_unstemmed The role of memory in non-genetic inheritance and its impact on cancer treatment resistance.
title_sort role of memory in non-genetic inheritance and its impact on cancer treatment resistance.
publisher Public Library of Science (PLoS)
publishDate 2021
url https://doaj.org/article/d6c120fed11b4ebeb8bb0479a0ce7d3f
work_keys_str_mv AT tylercassidy theroleofmemoryinnongeneticinheritanceanditsimpactoncancertreatmentresistance
AT danielnichol theroleofmemoryinnongeneticinheritanceanditsimpactoncancertreatmentresistance
AT markrobertsontessi theroleofmemoryinnongeneticinheritanceanditsimpactoncancertreatmentresistance
AT morgancraig theroleofmemoryinnongeneticinheritanceanditsimpactoncancertreatmentresistance
AT alexanderraanderson theroleofmemoryinnongeneticinheritanceanditsimpactoncancertreatmentresistance
AT tylercassidy roleofmemoryinnongeneticinheritanceanditsimpactoncancertreatmentresistance
AT danielnichol roleofmemoryinnongeneticinheritanceanditsimpactoncancertreatmentresistance
AT markrobertsontessi roleofmemoryinnongeneticinheritanceanditsimpactoncancertreatmentresistance
AT morgancraig roleofmemoryinnongeneticinheritanceanditsimpactoncancertreatmentresistance
AT alexanderraanderson roleofmemoryinnongeneticinheritanceanditsimpactoncancertreatmentresistance
_version_ 1718375808143196160